betaxolol has been researched along with Asthma in 13 studies
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| " A study was carried out to determine the prevalence of sensitivity to ophthalmic timolol in 24 asthmatic subjects at our institution and to determine the effect of ophthalmic betaxolol, a cardioselective beta-blocker efficacious in the treatment of glaucoma, in 8 subjects who were timolol-sensitive." | 9.06 | The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects. ( Cherniack, RM; Dunn, TL; Fernandez, E; Gerber, MJ; Iseman, MD; Shen, AS, 1986) |
| "To report a case of deterioration of asthma associated with continuous use of oral betaxolol, a beta1-selective beta-blocking agent." | 7.72 | Betaxolol-induced deterioration of asthma and a pharmacodynamic analysis based on beta-receptor occupancy. ( Miki, A; Ohtani, H; Sawada, Y; Tanaka, Y, 2003) |
| "We evaluated the use of topically administered betaxolol, a cardioselective beta-adrenergic blocking agent, in 11 patients (eight women and three men, 40 to 81 years old) who had asthma and severe glaucoma with increased intraocular pressure despite maximally tolerated medical therapy." | 7.67 | Betaxolol in patients with glaucoma and asthma. ( Berry, DP; Drake, MM; Lustgarten, JS; Podos, SM; Van Buskirk, EM; Weinreb, RN, 1986) |
| "Betaxolol 0." | 5.27 | Long-term betaxolol therapy in glaucoma patients with pulmonary disease. ( Cherniack, R; Drake, MM; van Buskirk, EM; Weinreb, RN, 1988) |
| " This study concerned 21 patients: 8 asthmatics and 13 spastic bronchitics, treated over a period of 4 months in a cross-over, double-blind test by 2 cardio-selective beta-blockers (2 months: betaxolol, 2 months atenolol)." | 5.06 | [Long-term beta adrenergic antagonists in spastic bronchopathies]. ( Blaive, B; Lemoigne, F; Lewest, G; Nahon, F, 1988) |
| " A study was carried out to determine the prevalence of sensitivity to ophthalmic timolol in 24 asthmatic subjects at our institution and to determine the effect of ophthalmic betaxolol, a cardioselective beta-blocker efficacious in the treatment of glaucoma, in 8 subjects who were timolol-sensitive." | 5.06 | The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects. ( Cherniack, RM; Dunn, TL; Fernandez, E; Gerber, MJ; Iseman, MD; Shen, AS, 1986) |
| "To report a case of deterioration of asthma associated with continuous use of oral betaxolol, a beta1-selective beta-blocking agent." | 3.72 | Betaxolol-induced deterioration of asthma and a pharmacodynamic analysis based on beta-receptor occupancy. ( Miki, A; Ohtani, H; Sawada, Y; Tanaka, Y, 2003) |
| "We evaluated the use of topically administered betaxolol, a cardioselective beta-adrenergic blocking agent, in 11 patients (eight women and three men, 40 to 81 years old) who had asthma and severe glaucoma with increased intraocular pressure despite maximally tolerated medical therapy." | 3.67 | Betaxolol in patients with glaucoma and asthma. ( Berry, DP; Drake, MM; Lustgarten, JS; Podos, SM; Van Buskirk, EM; Weinreb, RN, 1986) |
| "Betaxolol 0." | 1.27 | Long-term betaxolol therapy in glaucoma patients with pulmonary disease. ( Cherniack, R; Drake, MM; van Buskirk, EM; Weinreb, RN, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miki, A | 1 |
| Tanaka, Y | 1 |
| Ohtani, H | 1 |
| Sawada, Y | 1 |
| Schröder, H | 1 |
| Schoene, RB | 1 |
| Abuan, T | 1 |
| Ward, RL | 1 |
| Beasley, CH | 1 |
| Ananthanarayan, CR | 1 |
| Vaile, SJ | 1 |
| Feldman, F | 1 |
| Le Jeunne, C | 1 |
| Munera, Y | 1 |
| Hugues, FC | 1 |
| Berger, WE | 1 |
| Blaive, B | 1 |
| Nahon, F | 1 |
| Lemoigne, F | 1 |
| Lewest, G | 1 |
| Weinreb, RN | 2 |
| van Buskirk, EM | 2 |
| Cherniack, R | 1 |
| Drake, MM | 2 |
| Berry, DP | 1 |
| Lustgarten, JS | 1 |
| Podos, SM | 1 |
| Harris, LS | 1 |
| Greenstein, SH | 1 |
| Bloom, AF | 1 |
| Dunn, TL | 1 |
| Gerber, MJ | 1 |
| Shen, AS | 1 |
| Fernandez, E | 1 |
| Iseman, MD | 1 |
| Cherniack, RM | 1 |
| Spiritus, EM | 1 |
| Casciari, R | 1 |
2 trials available for betaxolol and Asthma
| Article | Year |
|---|---|
[Long-term beta adrenergic antagonists in spastic bronchopathies].
Topics: Adrenergic beta-Antagonists; Asthma; Atenolol; Betaxolol; Bronchitis; Drug Evaluation; Drug Toleranc | 1988 |
The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects.
Topics: Adult; Asthma; Betaxolol; Bronchodilator Agents; Female; Forced Expiratory Volume; Humans; Lung; Mal | 1986 |
11 other studies available for betaxolol and Asthma
| Article | Year |
|---|---|
Betaxolol-induced deterioration of asthma and a pharmacodynamic analysis based on beta-receptor occupancy.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Asthma; Betaxolol; Drug Therapy, Combinatio | 2003 |
[Increased intraocular pressure in asthma patients].
Topics: Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Betaxolol; Glaucoma; Glucocorticoids; Human | 2005 |
Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Asthma; Betaxolol; Double-Blind M | 1984 |
Systemic adverse reactions with betaxolol eye drops.
Topics: Aged; Asthma; Betaxolol; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Receptors, Adrener | 1995 |
Acute episode of asthma following topical administration of betaxolol eyedrops.
Topics: Acute Disease; Aged; Aged, 80 and over; Asthma; Betaxolol; Cataract Extraction; Female; Humans; Ocul | 1993 |
[Asthma and betaxolol eye-wash].
Topics: Asthma; Betaxolol; Blood Pressure; Female; Forced Expiratory Volume; Heart Rate; Humans; Male; Middl | 1991 |
Betaxolol in patients with glaucoma and asthma.
Topics: Adrenergic beta-Antagonists; Asthma; Betaxolol; Glaucoma; Humans; Propanolamines | 1987 |
Long-term betaxolol therapy in glaucoma patients with pulmonary disease.
Topics: Aged; Asthma; Betaxolol; Female; Glaucoma; Humans; Intraocular Pressure; Lung Diseases; Male; Middle | 1988 |
Betaxolol in patients with glaucoma and asthma.
Topics: Administration, Topical; Adult; Aged; Asthma; Betaxolol; Female; Glaucoma; Humans; Lung Volume Measu | 1986 |
Respiratory difficulties with betaxolol.
Topics: Aged; Airway Obstruction; Asthma; Betaxolol; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic | 1986 |
Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis.
Topics: Administration, Topical; Adult; Aged; Asthma; Betaxolol; Humans; Lung; Middle Aged; Propanolamines; | 1985 |